Longboard Pharmaceuticals Inc (NASDAQ: LBPH) Stock: Can It Go Higher?

In today’s recent session, 0.46 million shares of the Longboard Pharmaceuticals Inc (NASDAQ:LBPH) have been traded, and its beta is 1.17. Most recently the company’s share price was $20.22, and it changed around -$0.6 or -2.88% from the last close, which brings the market valuation of the company to $786.14M. LBPH at last check was trading at a discount to its 52-week high of $28.15, offering almost -39.22% off that amount. The share price’s 52-week low was $3.60, which indicates that the recent value has risen by an impressive 82.2% since then. We note from Longboard Pharmaceuticals Inc’s average daily trading volume that its 3-month average coming to 319.57K.

Longboard Pharmaceuticals Inc (NASDAQ:LBPH) trade information

Instantly LBPH has been showing red trend so far today with a performance of -2.88% on intraday trading today. The performance over the last five days has remained in the green territory. The company’s shares are currently up 235.32% year-to-date, but still up 7.38% over the last five days. On the other hand, Longboard Pharmaceuticals Inc (NASDAQ:LBPH) is 6.76% up in the 30-day period.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The consensus price target as assigned by Wall Street analysts is $29.33, which translates to bulls needing to increase their stock price by 31.06% from its current value. Analyst projections state that LBPH is forecast to be at a low of $16 and a high of $36.

Longboard Pharmaceuticals Inc (LBPH) estimates and forecasts

Longboard Pharmaceuticals Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 248.02 percent over the past six months and at a 23.85% annual growth rate that is well above the industry average of 15.60%.

4 analysts expect Longboard Pharmaceuticals Inc to make 3.75M in revenue for the current ending quarter.

LBPH Dividends

Longboard Pharmaceuticals Inc’s next quarterly earnings report is expected to be released in July.